Inhibition of endothelial cell proliferation by gamma-interferon

doi:10.1083/jcb.104.3.689

This Article

	Full Text (PDF, 1642K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Friesel, R.
	Articles by Maciag, T.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Friesel, R.
	Articles by Maciag, T.


Social Bookmarking

	What's this?

ARTICLES

Inhibition of endothelial cell proliferation by gamma-interferon

R Friesel, A Komoriya and T Maciag

Endothelial cell growth factor (ECGF) is a potent polypeptide mitogen for endothelial cells and fibroblasts. The mitogenic effects of ECGF are inhibited by the lymphokine gamma-interferon (gamma-IFN) in a dose- dependent manner. Gamma-IFN also induces a unique change in endothelial cell morphology which is maximally expressed in the presence of ECGF. The antiproliferative and phenotypic modulatory effects of gamma-IFN on endothelial cells are reversible. Inhibition of ECGF-induced endothelial cell proliferation by gamma-IFN is accompanied by a concentration- and time-dependent decrease in binding of 125I-ECGF to the endothelial cell surface. Scatchard analyses of the binding data in the presence and absence of gamma-IFN demonstrate a decrease in the number of ECGF-binding sites rather than a decrease in ligand affinity for the receptor. Cross-linking experiments with disuccinimidyl suberate demonstrate a decrease in the 170,000 Mr cross-linked receptor- ligand complex. These data suggest that gamma-IFN inhibits endothelial cell proliferation by a mechanism which involves growth factor receptor modulation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Weinlander, K., Naschberger, E., Lehmann, M. H., Tripal, P., Paster, W., Stockinger, H., Hohenadl, C., Sturzl, M. (2008). Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrin {alpha}4 expression. FASEB J. 22: 4168-4178 [Abstract] [Full Text]
Li, R., Maminishkis, A., Wang, F. E., Miller, S. S. (2007). PDGF-C and -D Induced Proliferation/Migration of Human RPE Is Abolished by Inflammatory Cytokines. IOVS 48: 5722-5732 [Abstract] [Full Text]
Indraccolo, S., Pfeffer, U., Minuzzo, S., Esposito, G., Roni, V., Mandruzzato, S., Ferrari, N., Anfosso, L., Dell'Eva, R., Noonan, D. M., Chieco-Bianchi, L., Albini, A., Amadori, A. (2007). Identification of Genes Selectively Regulated by IFNs in Endothelial Cells. J. Immunol. 178: 1122-1135 [Abstract] [Full Text]
Pacifico, L., Di Renzo, L., Anania, C., Osborn, J. F, Ippoliti, F., Schiavo, E., Chiesa, C. (2006). Increased T-helper interferon-{gamma}-secreting cells in obese children.. Eur J Endocrinol 154: 691-697 [Abstract] [Full Text]
Battle, T. E., Lynch, R. A., Frank, D. A. (2006). Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis.. Cancer Res. 66: 3649-3657 [Abstract] [Full Text]
Yamauchi, R., Tanaka, M., Kume, N., Minami, M., Kawamoto, T., Togi, K., Shimaoka, T., Takahashi, S., Yamaguchi, J., Nishina, T., Kitaichi, M., Komeda, M., Manabe, T., Yonehara, S., Kita, T. (2004). Upregulation of SR-PSOX/CXCL16 and Recruitment of CD8+ T Cells in Cardiac Valves During Inflammatory Valvular Heart Disease. Arterioscler. Thromb. Vasc. Bio. 24: 282-287 [Abstract] [Full Text]
Lubeseder-Martellato, C., Guenzi, E., Jorg, A., Topolt, K., Naschberger, E., Kremmer, E., Zietz, C., Tschachler, E., Hutzler, P., Schwemmle, M., Matzen, K., Grimm, T., Ensoli, B., Sturzl, M. (2002). Guanylate-Binding Protein-1 Expression Is Selectively Induced by Inflammatory Cytokines and Is an Activation Marker of Endothelial Cells during Inflammatory Diseases. Am. J. Pathol. 161: 1749-1759 [Abstract] [Full Text]
Hansson, G. K. (2001). Immune Mechanisms in Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 21: 1876-1890 [Abstract] [Full Text]
Fidler, I. J. (2000). Regulation of Neoplastic Angiogenesis. J Natl Cancer Inst Monogr 2000: 10-14 [Abstract] [Full Text]
Fathallah-Shaykh, H. M., Zhao, L.-J., Kafrouni, A. I., Smith, G. M., Forman, J. (2000). Gene Transfer of IFN-{gamma} into Established Brain Tumors Represses Growth by Antiangiogenesis. J. Immunol. 164: 217-222 [Abstract] [Full Text]
Kang, I.-C., Lee, Y.-D., Kim, D.-S. (1999). A Novel Disintegrin Salmosin Inhibits Tumor Angiogenesis. Cancer Res. 59: 3754-3760 [Abstract] [Full Text]
Lingen, M.W. (1999). Angiogenesis in the Development of Head and Neck Cancer and Its Inhibition By Chemopreventive Agents. CROBM 10: 153-164 [Abstract] [Full Text]
HAYASAKA, S., NAGAKI, Y., MATSUMOTO, M., SATO, S. (1998). Interferon associated retinopathy. Br J Ophthalmol 82: 323-325 [Full Text]
Tamayo, L., Ortiz, D. M., Orozco-Covarrubias, L., Duran-McKinster, C., Mora, M. A., Avila, E., Teixeira, F., Ruiz-Maldonado, R. (1997). Therapeutic Efficacy of Interferon Alfa-2b in Infants With Life-Threatening Giant Hemangiomas. Arch Dermatol 133: 1567-1571 [Abstract]
Pharmacological Therapy for Macular Degeneration S, (1997). Interferon Alfa-2a Is Ineffective for Patients With Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: Results of a Prospective Randomized Placebo-Controlled Clinical Trial. Arch Ophthalmol 115: 865-872 [Abstract]
Takashima, S., Klagsbrun, M. (1996). Inhibition of Endothelial Cell Growth by Macrophage-like U-937 Cell-derived Oncostatin M, Leukemia Inhibitory Factor, and Transforming Growth Factor beta 1. J. Biol. Chem. 271: 24901-24906 [Abstract] [Full Text]
Camejo, E. H., Rosengren, B., Camejo, G., Sartipy, P., Fager, G., Bondjers, G. (1995). Interferon Gamma Binds to Extracellular Matrix Chondroitin-Sulfate Proteoglycans, Thus Enhancing Its Cellular Response. Arterioscler. Thromb. Vasc. Bio. 15: 1456-1465 [Abstract] [Full Text]
Guyer, D. R., Tiedeman, J., Yannuzzi, L. A., Slakter, J. S., Parke, D., Kelley, J., Tang, R. A., Marmor, M., Abrams, G., Miller, J. W., Gragoudas, E. S. (1993). Interferon-Associated Retinopathy. Arch Ophthalmol 111: 350-356 [Abstract]
Fenyves, A., Behrens, J, Spanel-Borowski, K (1993). Cultured microvascular endothelial cells (MVEC) differ in cytoskeleton, expression of cadherins and fibronectin matrix. A study under the influence of interferon-gamma. J. Cell Sci. 106: 879-890 [Abstract]
Guyer, D. R., Adamis, A. P., Gragoudas, E. S., Folkman, J., Slakter, J. S., Yannuzzi, L. A. (1992). Systemic Antiangiogenic Therapy for Choroidal Neovascularization: What Is the Role of Interferon Alfa?. Arch Ophthalmol 110: 1383-1384 [Abstract]
Maier, J., Voulalas, P, Roeder, D, Maciag, T (1990). Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science 249: 1570-1574 [Abstract]
Papetti, M., Herman, I. M. (2002). Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol. 282: C947-C970 [Abstract] [Full Text]